Ken Fisher Fisher Asset Management
AUM
$293B
1-Year Est. Return
28.33%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Fund
S&P 500
1 Year Est. Return
+28.33%
AUM
$276B
AUM Growth
+$24.4B
(+9.7%)
Holding
1,094
Top Buys
| 1 | +$2.87B | |
| 2 | +$358M | |
| 3 | +$287M | |
| 4 |
Microsoft
MSFT
|
+$278M |
| 5 |
Apple
AAPL
|
+$200M |
Top Sells
| 1 | +$1.8B | |
| 2 | +$205M | |
| 3 | +$177M | |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
Chart Industries
GTLS
|
+$95.2M |
Sector Composition
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
RenaissanceRe
RNR
$13.5B
| $19.6M | 0.01% |
77,288
-1,993
|
|
||
327
Amkor Technology
AMKR
$19B
| $19.5M | 0.01% |
687,918
+65,485
|
|
||
328
Ligand Pharmaceuticals
LGND
$4.73B
| $19.3M | 0.01% |
108,926
+2,860
|
|
||
329
Edwards Lifesciences
EW
$48.5B
| $19.2M | 0.01% |
247,420
-68,972
|
|
||
330
Sanmina
SANM
$10.2B
| $19.2M | 0.01% |
+166,861
|
|
||
331
Worthington Enterprises
WOR
$2.74B
| $19.1M | 0.01% |
343,591
+55,917
|
|
||
332
Wipro
WIT
$21.4B
| $18.9M | 0.01% |
7,197,876
+177,146
|
|
||
333
Snap-on
SNA
$19.6B
| $18.8M | 0.01% |
54,209
+8,678
|
|
||
334
Ovintiv
OVV
$16.1B
| $18.7M | 0.01% |
463,441
-35,451
|
|
||
335
CONMED
CNMD
$1.2B
| $18.7M | 0.01% |
397,046
+33,725
|
|
||
336
Boston Properties
BXP
$9.2B
| $18.6M | 0.01% |
250,316
+39,682
|
|
||
337
AAR Corp
AIR
$4.39B
| $18.6M | 0.01% |
207,000
-1
|
|
||
338
Merit Medical Systems
MMSI
$4.07B
| $18.4M | 0.01% |
221,609
+6,164
|
|
||
339
Fluor
FLR
$7.19B
| $18.4M | 0.01% |
437,164
+121,057
|
|
||
340
Prestige Consumer Healthcare
PBH
$2.81B
| $18.3M | 0.01% |
293,709
-11,917
|
|
||
341
First Financial Bancorp
FFBC
$3.23B
| $18.2M | 0.01% |
722,400
-48,199
|
|
||
342
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.39B
| $18M | 0.01% |
765,206
-253,151
|
|
||
343
Materion
MTRN
$3.83B
| $18M | 0.01% |
148,697
+21,529
|
|
||
344
ITT
ITT
$19.4B
| $17.9M | 0.01% |
100,412
-5,453
|
|
||
345
Berkshire Hathaway Class B
BRK.B
$1.02T
| $17.8M | 0.01% |
35,468
-542
|
|
||
346
DexCom
DXCM
$23.9B
| $17.7M | 0.01% |
263,564
-23,056
|
|
||
347
Qualys
QLYS
$3.04B
| $17.4M | 0.01% |
131,652
-12,350
|
|
||
348
Trex
TREX
$4.4B
| $17M | 0.01% |
329,124
+52,508
|
|
||
349
Azenta
AZTA
$1.19B
| $16.8M | 0.01% |
586,289
-48,408
|
|
||
350
Tanger
SKT
$4.18B
| $16.7M | 0.01% |
492,568
-12,363
|
|